Australia's largest stock trading and investment forum Australia's #1 stock forum

RFX

Click for more information

0.00%

9.7¢ redflow limited

My guess is the Gen 3 manufacturing cost in the range of $4 to...

First 47 Last

Share
Profile

Follow
dyeman

4,203 Posts.

786

25/08/22

11:46

Post #: 63316411
Share

Originally posted by tanon ↑

Weighting doesn't mean anything for speculative stocks but % of portfolio is relevant - I wouldn't invest any more than a fraction of a percent of my total funds invested in shares and derivatives in any speculative stock but I have and do holding quite a lot more in what were speculative stocks at one time.

RFX is still speculative with a chance of making it, particularly in the current changing environment (cue dyode). Everyone must realize speculative stocks are very risky and might not make it in which case shareholders lose what they have invested.

I would still like to have on HC opinions / the best guess on the cost per kwh of storage of Gen3 i.e. how much more (less) per kwh would 20 Gen3s be than than say 20 Powerwalls.

My guess is somewhere between $1000 and $3000 per kwh of storage for Gen3 - can anyone narrow that down?

Expand

My guess is the Gen 3 manufacturing cost in the range of $4 to 5k (or will be once manufacturing volumes lead to reduced costs e.g. for the electrolyte). So need to add corporate overheads, R&D, profit margin, and for a complete system all of the other bits and pieces (inverters, enclosures, electronics for LSB-type system such as Anaergia etc).

RFX Price at posting: 4.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 4 more messages in this thread...

First 47 Last

Add RFX (ASX) to my watchlist